Wednesday, October 14, 2015

Faruqi & Faruqi Investigation: BioMed Realty Trust, Inc.

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of BioMed Realty Trust, Inc. (“BioMed” or the “Company”) (NYSE:BMR) for potential breaches of fiduciary duties in connection with the sale of the Company to Blackstone for approximately $8 billion in a cash transaction, including debt. 
The Company’s stockholders will only receive $23.75 for each share of BioMed common stock they own. However, the offer is inadequate since BioMed shares have traded as high as $25.11 as recently as January.
If you own common stock in BioMed and wish to obtain additional information and protect your investments free of charge, please contact Juan E. Monteverde, Esq. either via e-mail at or by telephone at (877) 247-4292 or (212) 983-9330. 

No comments:

Post a Comment